1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Acromegaly Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Ectopic Acromegaly 1.2.3 Pseudo Acromegaly 1.3 Market by Application 1.3.1 Global Acromegaly Treatment Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Surgery 1.3.3 Drug Therapy 1.3.4 Radiation Therapy 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Acromegaly Treatment Market Size (2017-2028) 2.2 Acromegaly Treatment Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Acromegaly Treatment Market Size by Region (2017-2022) 2.4 Global Acromegaly Treatment Market Size Forecast by Region (2023-2028) 2.5 Global Top Acromegaly Treatment Countries Ranking by Market Size 3 Acromegaly Treatment Competitive by Company 3.1 Global Acromegaly Treatment Revenue by Players 3.1.1 Global Acromegaly Treatment Revenue by Players (2017-2022) 3.1.2 Global Acromegaly Treatment Market Share by Players (2017-2022) 3.2 Global Acromegaly Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Acromegaly Treatment Revenue 3.4 Global Acromegaly Treatment Market Concentration Ratio 3.4.1 Global Acromegaly Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Acromegaly Treatment Revenue in 2021 3.5 Global Acromegaly Treatment Key Players Head office and Area Served 3.6 Key Players Acromegaly Treatment Product Solution and Service 3.7 Date of Enter into Acromegaly Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Acromegaly Treatment Breakdown Data by Type 4.1 Global Acromegaly Treatment Historic Revenue by Type (2017-2022) 4.2 Global Acromegaly Treatment Forecasted Revenue by Type (2023-2028) 5 Global Acromegaly Treatment Breakdown Data by Application 5.1 Global Acromegaly Treatment Historic Market Size by Application (2017-2022) 5.2 Global Acromegaly Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Acromegaly Treatment Revenue by Company (2020-2022) 6.2 North America Acromegaly Treatment Revenue by Type (2017-2028) 6.3 North America Acromegaly Treatment Revenue by Application (2017-2028) 6.4 North America Acromegaly Treatment Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Acromegaly Treatment Revenue by Company (2020-2022) 7.2 Europe Acromegaly Treatment Revenue by Type (2017-2028) 7.3 Europe Acromegaly Treatment Revenue by Application (2017-2028) 7.4 Europe Acromegaly Treatment Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Acromegaly Treatment Revenue by Company (2020-2022) 8.2 Asia Pacific Acromegaly Treatment Revenue by Type (2017-2028) 8.3 Asia Pacific Acromegaly Treatment Revenue by Application (2017-2028) 8.4 Asia Pacific Acromegaly Treatment Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Acromegaly Treatment Revenue by Company (2020-2022) 9.2 Latin America Acromegaly Treatment Revenue by Type (2017-2028) 9.3 Latin America Acromegaly Treatment Revenue by Application (2017-2028) 9.4 Latin America Acromegaly Treatment Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Acromegaly Treatment Revenue by Company (2020-2022) 10.2 Middle East and Africa Acromegaly Treatment Revenue by Type (2017-2028) 10.3 Middle East and Africa Acromegaly Treatment Revenue by Application (2017-2028) 10.4 Middle East and Africa Acromegaly Treatment Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 11 Company Profiles 11.1 Pfizer Inc. 11.1.1 Pfizer Inc. Company Details 11.1.2 Pfizer Inc. Business Overview 11.1.3 Pfizer Inc. Acromegaly Treatment Products and Services 11.1.4 Pfizer Inc. Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) 11.1.5 Pfizer Inc. Acromegaly Treatment SWOT Analysis 11.1.6 Pfizer Inc. Recent Developments 11.2 Chiasma Inc 11.2.1 Chiasma Inc Company Details 11.2.2 Chiasma Inc Business Overview 11.2.3 Chiasma Inc Acromegaly Treatment Products and Services 11.2.4 Chiasma Inc Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) 11.2.5 Chiasma Inc Acromegaly Treatment SWOT Analysis 11.2.6 Chiasma Inc Recent Developments 11.3 Novartis AG 11.3.1 Novartis AG Company Details 11.3.2 Novartis AG Business Overview 11.3.3 Novartis AG Acromegaly Treatment Products and Services 11.3.4 Novartis AG Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) 11.3.5 Novartis AG Acromegaly Treatment SWOT Analysis 11.3.6 Novartis AG Recent Developments 11.4 Ipsen Biopharmaceuticals Inc 11.4.1 Ipsen Biopharmaceuticals Inc Company Details 11.4.2 Ipsen Biopharmaceuticals Inc Business Overview 11.4.3 Ipsen Biopharmaceuticals Inc Acromegaly Treatment Products and Services 11.4.4 Ipsen Biopharmaceuticals Inc Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) 11.4.5 Ipsen Biopharmaceuticals Inc Acromegaly Treatment SWOT Analysis 11.4.6 Ipsen Biopharmaceuticals Inc Recent Developments 11.5 Wockhardt Ltd. 11.5.1 Wockhardt Ltd. Company Details 11.5.2 Wockhardt Ltd. Business Overview 11.5.3 Wockhardt Ltd. Acromegaly Treatment Products and Services 11.5.4 Wockhardt Ltd. Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) 11.5.5 Wockhardt Ltd. Acromegaly Treatment SWOT Analysis 11.5.6 Wockhardt Ltd. Recent Developments 11.6 Troikaa Pharmaceuticals Limited 11.6.1 Troikaa Pharmaceuticals Limited Company Details 11.6.2 Troikaa Pharmaceuticals Limited Business Overview 11.6.3 Troikaa Pharmaceuticals Limited Acromegaly Treatment Products and Services 11.6.4 Troikaa Pharmaceuticals Limited Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) 11.6.5 Troikaa Pharmaceuticals Limited Acromegaly Treatment SWOT Analysis 11.6.6 Troikaa Pharmaceuticals Limited Recent Developments 11.7 VHB Life Sciences Limited 11.7.1 VHB Life Sciences Limited Company Details 11.7.2 VHB Life Sciences Limited Business Overview 11.7.3 VHB Life Sciences Limited Acromegaly Treatment Products and Services 11.7.4 VHB Life Sciences Limited Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) 11.7.5 VHB Life Sciences Limited Acromegaly Treatment SWOT Analysis 11.7.6 VHB Life Sciences Limited Recent Developments 11.8 GlaxoSmithKline plc 11.8.1 GlaxoSmithKline plc Company Details 11.8.2 GlaxoSmithKline plc Business Overview 11.8.3 GlaxoSmithKline plc Acromegaly Treatment Products and Services 11.8.4 GlaxoSmithKline plc Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) 11.8.5 GlaxoSmithKline plc Acromegaly Treatment SWOT Analysis 11.8.6 GlaxoSmithKline plc Recent Developments 12 Acromegaly Treatment Market Dynamics 12.1 Acromegaly Treatment Market Trends 12.2 Acromegaly Treatment Market Drivers 12.3 Acromegaly Treatment Market Challenges 12.4 Acromegaly Treatment Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Acromegaly Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Ectopic Acromegaly Table 3. Key Players of Pseudo Acromegaly Table 4. Global Acromegaly Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Acromegaly Treatment Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 6. Global Acromegaly Treatment Revenue by Region (2017-2022) & (US$ Million) Table 7. Global Acromegaly Treatment Revenue Market Share by Region (2017-2022) Table 8. Global Acromegaly Treatment Revenue by Players (2017-2022) & (US$ Million) Table 9. Global Acromegaly Treatment Market Share by Players (2017-2022) Table 10. Global Top Acromegaly Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acromegaly Treatment as of 2021) Table 11. Ranking of Global Top Acromegaly Treatment Companies by Revenue (US$ Million) in 2021 Table 12. Global 5 Largest Players Market Share by Acromegaly Treatment Revenue (CR5 and HHI) & (2017-2022) Table 13. Key Players Headquarters and Area Served Table 14. Key Players Acromegaly Treatment Product Solution and Service Table 15. Date of Key Manufacturers Enter into Acromegaly Treatment Market Table 16. Mergers & Acquisitions, Expansion Plans Table 17. Global Acromegaly Treatment Market Size by Type (2017-2022) & (US$ Million) Table 18. Global Acromegaly Treatment Revenue Market Share by Type (2017-2022) Table 19. Global Acromegaly Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 20. Global Acromegaly Treatment Revenue Market Share by Type (2023-2028) Table 21. Global Acromegaly Treatment Market Size by Application (2017-2022) & (US$ Million) Table 22. Global Acromegaly Treatment Revenue Market Share by Application (2017-2022) Table 23. Global Acromegaly Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 24. Global Acromegaly Treatment Revenue Market Share by Application (2023-2028) Table 25. North America Acromegaly Treatment Revenue by Company (2020-2022) & (US$ Million) Table 26. North America Acromegaly Treatment Revenue by Type (2017-2022) & (US$ Million) Table 27. North America Acromegaly Treatment Revenue by Type (2023-2028) & (US$ Million) Table 28. North America Acromegaly Treatment Revenue by Application (2017-2022) & (US$ Million) Table 29. North America Acromegaly Treatment Revenue by Application (2023-2028) & (US$ Million) Table 30. North America Acromegaly Treatment Revenue by Country (2017-2022) & (US$ Million) Table 31. North America Acromegaly Treatment Revenue by Country (2023-2028) & (US$ Million) Table 32. Europe Acromegaly Treatment Revenue by Company (2020-2022) & (US$ Million) Table 33. Europe Acromegaly Treatment Revenue by Type (2017-2022) & (US$ Million) Table 34. Europe Acromegaly Treatment Revenue by Type (2023-2028) & (US$ Million) Table 35. Europe Acromegaly Treatment Revenue by Application (2017-2022) & (US$ Million) Table 36. Europe Acromegaly Treatment Revenue by Application (2023-2028) & (US$ Million) Table 37. Europe Acromegaly Treatment Revenue by Country (2017-2022) & (US$ Million) Table 38. Europe Acromegaly Treatment Revenue by Country (2023-2028) & (US$ Million) Table 39. Asia Pacific Acromegaly Treatment Revenue by Company (2020-2022) & (US$ Million) Table 40. Asia Pacific Acromegaly Treatment Revenue by Type (2017-2022) & (US$ Million) Table 41. Asia Pacific Acromegaly Treatment Revenue by Type (2023-2028) & (US$ Million) Table 42. Asia Pacific Acromegaly Treatment Revenue by Application (2017-2022) & (US$ Million) Table 43. Asia Pacific Acromegaly Treatment Revenue by Application (2023-2028) & (US$ Million) Table 44. Asia Pacific Acromegaly Treatment Revenue by Region (2017-2022) & (US$ Million) Table 45. Asia Pacific Acromegaly Treatment Revenue by Region (2023-2028) & (US$ Million) Table 46. Latin America Acromegaly Treatment Revenue by Company (2020-2022) & (US$ Million) Table 47. Latin America Acromegaly Treatment Revenue by Type (2017-2022) & (US$ Million) Table 48. Latin America Acromegaly Treatment Revenue by Type (2023-2028) & (US$ Million) Table 49. Latin America Acromegaly Treatment Revenue by Application (2017-2022) & (US$ Million) Table 50. Latin America Acromegaly Treatment Revenue by Application (2023-2028) & (US$ Million) Table 51. Latin America Acromegaly Treatment Revenue by Country (2017-2022) & (US$ Million) Table 52. Latin America Acromegaly Treatment Revenue by Country (2023-2028) & (US$ Million) Table 53. Middle East and Africa Acromegaly Treatment Revenue by Company (2020-2022) & (US$ Million) Table 54. Middle East and Africa Acromegaly Treatment Revenue by Type (2017-2022) & (US$ Million) Table 55. Middle East and Africa Acromegaly Treatment Revenue by Type (2023-2028) & (US$ Million) Table 56. Middle East and Africa Acromegaly Treatment Revenue by Application (2017-2022) & (US$ Million) Table 57. Middle East and Africa Acromegaly Treatment Revenue by Application (2023-2028) & (US$ Million) Table 58. Middle East and Africa Acromegaly Treatment Revenue by Country (2017-2022) & (US$ Million) Table 59. Middle East and Africa Acromegaly Treatment Revenue by Country (2023-2028) & (US$ Million) Table 60. Pfizer Inc. Company Details Table 61. Pfizer Inc. Business Overview Table 62. Pfizer Inc. Acromegaly Treatment Product and Services Table 63. Pfizer Inc. Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) & (US$ Million) Table 64. Pfizer Inc. Acromegaly Treatment SWOT Analysis Table 65. Pfizer Inc. Recent Developments Table 66. Chiasma Inc Company Details Table 67. Chiasma Inc Business Overview Table 68. Chiasma Inc Acromegaly Treatment Product and Services Table 69. Chiasma Inc Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) & (US$ Million) Table 70. Chiasma Inc Acromegaly Treatment SWOT Analysis Table 71. Chiasma Inc Recent Developments Table 72. Novartis AG Company Details Table 73. Novartis AG Business Overview Table 74. Novartis AG Acromegaly Treatment Product and Services Table 75. Novartis AG Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) & (US$ Million) Table 76. Novartis AG Acromegaly Treatment SWOT Analysis Table 77. Novartis AG Recent Developments Table 78. Ipsen Biopharmaceuticals Inc Company Details Table 79. Ipsen Biopharmaceuticals Inc Business Overview Table 80. Ipsen Biopharmaceuticals Inc Acromegaly Treatment Product and Services Table 81. Ipsen Biopharmaceuticals Inc Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) & (US$ Million) Table 82. Ipsen Biopharmaceuticals Inc Acromegaly Treatment SWOT Analysis Table 83. Ipsen Biopharmaceuticals Inc Recent Developments Table 84. Wockhardt Ltd. Company Details Table 85. Wockhardt Ltd. Business Overview Table 86. Wockhardt Ltd. Acromegaly Treatment Product and Services Table 87. Wockhardt Ltd. Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) & (US$ Million) Table 88. Wockhardt Ltd. Acromegaly Treatment SWOT Analysis Table 89. Wockhardt Ltd. Recent Developments Table 90. Troikaa Pharmaceuticals Limited Company Details Table 91. Troikaa Pharmaceuticals Limited Business Overview Table 92. Troikaa Pharmaceuticals Limited Acromegaly Treatment Product and Services Table 93. Troikaa Pharmaceuticals Limited Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) & (US$ Million) Table 94. Troikaa Pharmaceuticals Limited Acromegaly Treatment SWOT Analysis Table 95. Troikaa Pharmaceuticals Limited Recent Developments Table 96. VHB Life Sciences Limited Company Details Table 97. VHB Life Sciences Limited Business Overview Table 98. VHB Life Sciences Limited Acromegaly Treatment Product and Services Table 99. VHB Life Sciences Limited Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) & (US$ Million) Table 100. VHB Life Sciences Limited Acromegaly Treatment SWOT Analysis Table 101. VHB Life Sciences Limited Recent Developments Table 102. GlaxoSmithKline plc Company Details Table 103. GlaxoSmithKline plc Business Overview Table 104. GlaxoSmithKline plc Acromegaly Treatment Product and Services Table 105. GlaxoSmithKline plc Acromegaly Treatment Revenue in Acromegaly Treatment Business (2017-2022) & (US$ Million) Table 106. GlaxoSmithKline plc Acromegaly Treatment SWOT Analysis Table 107. GlaxoSmithKline plc Recent Developments Table 108. Acromegaly Treatment Market Trends Table 109. Acromegaly Treatment Market Drivers Table 110. Acromegaly Treatment Market Challenges Table 111. Acromegaly Treatment Market Restraints Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Acromegaly Treatment Sales Market Share by Type: 2021 VS 2028 Figure 2. Ectopic Acromegaly Features Figure 3. Pseudo Acromegaly Features Figure 4. Global Acromegaly Treatment Sales Market Share by Application: 2021 VS 2028 Figure 5. Surgery Case Studies Figure 6. Drug Therapy Case Studies Figure 7. Radiation Therapy Case Studies Figure 8. Acromegaly Treatment Report Years Considered Figure 9. Global Acromegaly Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Acromegaly Treatment Market Size 2017-2028 (US$ Million) Figure 11. Global Acromegaly Treatment Market Size Market Share by Region: 2021 VS 2028 Figure 12. Global Acromegaly Treatment Revenue Market Share by Region in 2017 VS 2022 Figure 13. Global Top 10 Acromegaly Treatment Countries Ranking by Market Size (US$ Million) in 2021 Figure 14. Global Acromegaly Treatment Market Share by Players in 2021 Figure 15. Global Top Acromegaly Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acromegaly Treatment as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Acromegaly Treatment Revenue in 2021 Figure 17. North America Acromegaly Treatment Revenue Market Share by Company in 2021 Figure 18. North America Acromegaly Treatment Revenue Market Share by Type (2017-2028) Figure 19. North America Acromegaly Treatment Revenue Market Share by Application (2017-2028) Figure 20. North America Acromegaly Treatment Revenue Share by Country (2017-2028) Figure 21. U.S. Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 22. Canada Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 23. Europe Acromegaly Treatment Revenue Market Share by Company in 2021 Figure 24. Europe Acromegaly Treatment Revenue Market Share by Type (2017-2028) Figure 25. Europe Acromegaly Treatment Revenue Market Share by Application (2017-2028) Figure 26. Europe Acromegaly Treatment Revenue Share by Country (2017-2028) Figure 27. Germany Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 28. France Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 29. U.K. Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 30. Italy Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 31. Russia Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 32. Asia Pacific Acromegaly Treatment Revenue Market Share by Company in 2021 Figure 33. Asia Pacific Acromegaly Treatment Revenue Market Share by Type (2017-2028) Figure 34. Asia Pacific Acromegaly Treatment Revenue Market Share by Application (2017-2028) Figure 35. Asia Pacific Acromegaly Treatment Revenue Share by Region (2017-2028) Figure 36. China Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 37. Japan Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 38. South Korea Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 39. India Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 40. Australia Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 41. Taiwan Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 42. Indonesia Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 43. Thailand Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 44. Malaysia Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 45. Philippines Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 46. Vietnam Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 47. Latin America Acromegaly Treatment Revenue Market Share by Company in 2021 Figure 48. Latin America Acromegaly Treatment Revenue Market Share by Type (2017-2028) Figure 49. Latin America Acromegaly Treatment Revenue Market Share by Application (2017-2028) Figure 50. Latin America Acromegaly Treatment Revenue Share by Country (2017-2028) Figure 51. Mexico Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 52. Brazil Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 53. Argentina Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 54. Middle East and Africa Acromegaly Treatment Revenue Market Share by Company in 2021 Figure 55. Middle East and Africa Acromegaly Treatment Revenue Market Share by Type (2017-2028) Figure 56. Middle East and Africa Acromegaly Treatment Revenue Market Share by Application (2017-2028) Figure 57. Middle East and Africa Acromegaly Treatment Revenue Share by Country (2017-2028) Figure 58. Turkey Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 59. Saudi Arabia Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 60. UAE Acromegaly Treatment Revenue (2017-2028) & (US$ Million) Figure 61. Pfizer Inc. Revenue Growth Rate in Acromegaly Treatment Business (2017-2022) Figure 62. Chiasma Inc Revenue Growth Rate in Acromegaly Treatment Business (2017-2022) Figure 63. Novartis AG Revenue Growth Rate in Acromegaly Treatment Business (2017-2022) Figure 64. Ipsen Biopharmaceuticals Inc Revenue Growth Rate in Acromegaly Treatment Business (2017-2022) Figure 65. Wockhardt Ltd. Revenue Growth Rate in Acromegaly Treatment Business (2017-2022) Figure 66. Troikaa Pharmaceuticals Limited Revenue Growth Rate in Acromegaly Treatment Business (2017-2022) Figure 67. VHB Life Sciences Limited Revenue Growth Rate in Acromegaly Treatment Business (2017-2022) Figure 68. GlaxoSmithKline plc Revenue Growth Rate in Acromegaly Treatment Business (2017-2022) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Pfizer Inc. Chiasma Inc Novartis AG Ipsen Biopharmaceuticals Inc Wockhardt Ltd. Troikaa Pharmaceuticals Limited VHB Life Sciences Limited GlaxoSmithKline plc